Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway
Clinical and Experimental Nephrology · 2024
DOI: 10.1007/s10157-024-02504-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, 2024. Verfasst von Yanying Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephropathy, Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Benzylisoquinolines, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Chongqing Municipal Natural Science Foundation, Chengdu University of Traditional Chinese Medicine 2021 Xinglin Scholars Hospital Special Project, Chongqing Research Institutions Performance Incentive and Guidance Project.
Abstract (Originalsprache)
Acute kidney injury (AKI) is a cluster of clinical syndromes with diverse etiologies that ultimately result in a swift decline in kidney function. Regrettably, AKI lacks effective therapeutic agents at present. Neferine, a bioactive alkaloid derived from Lotus Plumule, has been reported to alleviate AKI triggered by cisplatin, ischemia/reperfusion (I/R), and sepsis by inhibiting inflammatory pathways. However, the precise molecular mechanisms underpinning its renoprotective effects remain elusive. Peroxisome proliferator-activated receptor alpha (PPAR-α), a regulator of lipid metabolism with anti-inflammatory properties, was investigated in this study to examine its role in neferine's renoprotective effects in cellular and mouse models of AKI. We found that neferine pretreatment in both I/R- or lipopolysaccharide (LPS)-induced AKI models inhibited the activation of the NF-κB inflammatory pathway and reversed PPAR-α deficiency. In NRK-52E cells exposed to hypoxia/reoxygenation (H/R) or LPS, overexpression of PPAR-α resulted in inhibition of the NF-κB pathway and TNF-α production, while PPAR-α silencing via siRNA transfection negated neferine's anti-inflammatory effects. Furthermore, pretreatment with neferine not only reduced lipid accumulation but also reversed the downregulation of FAO-related enzymes induced by LPS. Our findings suggest that neferine's renoprotective effects against AKI are partially mediated through the reversal of renal PPAR-α deficiency and subsequent inhibition of the inflammatory NF-κB pathway. Therefore, regulating renal PPAR-α expression by neferine could represent a promising therapeutic strategy for AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephropathy, Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China.
- Department of Nephropathy, Xiangya Hospital Central-South University, Changsha, Hunan, China.
- Department of Nephropathy, Chongqing Hospital of Traditional Chinese Medicine, Jiangbei District, Chongqing, China. 932933981@qq.com.
Förderung
- Chongqing Municipal Natural Science Foundation
- Chengdu University of Traditional Chinese Medicine 2021 Xinglin Scholars Hospital Special Project
- Chongqing Research Institutions Performance Incentive and Guidance Project
Zitieren
APA
Xiong, Y., Zhong, J., Chen, W., Li, X., Liu, H., Li, Y., Xiong, W., & Li, H. (2024). Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02504-8
Vancouver
Xiong Y, Zhong J, Chen W, Li X, Liu H, Li Y, et al. Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway. Clinical and Experimental Nephrology. 2024. doi:10.1007/s10157-024-02504-8
BibTeX
@article{Xiong2024,
author = {Xiong, Yanying and Zhong, Jin and Chen, Wenhang and Li, Xuan and Liu, Hong and Li, Ying and Xiong, Weijian and Li, Huihui},
title = {Neferine alleviates acute kidney injury by regulating the PPAR-α/NF-κB pathway},
journal = {Clinical and Experimental Nephrology},
year = {2024},
doi = {10.1007/s10157-024-02504-8}
}
EUVIMED